Anti-CD3ε mAb improves thymic architecture and prevents autoimmune manifestations in a mouse model of Omenn syndrome: Therapeutic implications

Veronica Marrella, Pietro L. Poliani, Elena Fontana, Anna Casati, Virginia Maina, Barbara Cassani, Francesca Ficara, Manuela Cominelli, Francesca Schena, Marianna Paulis, Elisabetta Traggiai, Paolo Vezzoni, Fabio Grassi, Anna Villa

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Omenn syndrome (OS) is an atypical primary immunodeficiency characterized by severe autoimmunity because of activated T cells infiltrating target organs. The impaired recombinase activity in OS severely affects expression of the pre- T-cell receptor complex in immature thymocytes, which is crucial for an efficient development of the thymic epithelial component. Anti-CD3ε monoclonal antibody (mAb) treatment in RAG2 -/- mice was previously shown to mimic pre-TCR signaling promoting thymic expansion. Here we show the effect of anti-CD3ε mAb administration in the RAG2 R229Q mouse model, which closely recapitulates human OS. These animals, in spite of the inability to induce the autoimmune regulator, displayed a significant amelioration in thymic epithelial compartment and an important reduction of peripheral T-cell activation and tissue infiltration. Furthermore, by injecting a high number of RAG2 R229Q progenitors into RAG2 -/- animals previously conditioned with anti-CD3ε mAb, we detected autoimmune regulator expression together with the absence of peripheral immunopathology. These observations indicate that improving epithelial thymic function might ameliorate the detrimental behavior of the cell-autonomous RAG defect. Our data provide important therapeutic proof of concept for future clinical applications of anti-CD3ε mAb treatment in severe combined immunodeficiency forms characterized by poor thymus function and autoimmunity.

Original languageEnglish
Pages (from-to)1005-1014
Number of pages10
JournalBlood
Volume120
Issue number5
DOIs
Publication statusPublished - Aug 2 2012

Fingerprint

Severe Combined Immunodeficiency
Monoclonal Antibodies
T-cells
Autoimmunity
Animals
T-Lymphocytes
Thymus
Recombinases
Thymocytes
Therapeutics
T-Cell Antigen Receptor
Infiltration
Thymus Gland
Chemical activation
Cells
Tissue
Defects

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

Anti-CD3ε mAb improves thymic architecture and prevents autoimmune manifestations in a mouse model of Omenn syndrome : Therapeutic implications. / Marrella, Veronica; Poliani, Pietro L.; Fontana, Elena; Casati, Anna; Maina, Virginia; Cassani, Barbara; Ficara, Francesca; Cominelli, Manuela; Schena, Francesca; Paulis, Marianna; Traggiai, Elisabetta; Vezzoni, Paolo; Grassi, Fabio; Villa, Anna.

In: Blood, Vol. 120, No. 5, 02.08.2012, p. 1005-1014.

Research output: Contribution to journalArticle

Marrella, Veronica ; Poliani, Pietro L. ; Fontana, Elena ; Casati, Anna ; Maina, Virginia ; Cassani, Barbara ; Ficara, Francesca ; Cominelli, Manuela ; Schena, Francesca ; Paulis, Marianna ; Traggiai, Elisabetta ; Vezzoni, Paolo ; Grassi, Fabio ; Villa, Anna. / Anti-CD3ε mAb improves thymic architecture and prevents autoimmune manifestations in a mouse model of Omenn syndrome : Therapeutic implications. In: Blood. 2012 ; Vol. 120, No. 5. pp. 1005-1014.
@article{fe92406be40e4d609273a209189bc5a4,
title = "Anti-CD3ε mAb improves thymic architecture and prevents autoimmune manifestations in a mouse model of Omenn syndrome: Therapeutic implications",
abstract = "Omenn syndrome (OS) is an atypical primary immunodeficiency characterized by severe autoimmunity because of activated T cells infiltrating target organs. The impaired recombinase activity in OS severely affects expression of the pre- T-cell receptor complex in immature thymocytes, which is crucial for an efficient development of the thymic epithelial component. Anti-CD3ε monoclonal antibody (mAb) treatment in RAG2 -/- mice was previously shown to mimic pre-TCR signaling promoting thymic expansion. Here we show the effect of anti-CD3ε mAb administration in the RAG2 R229Q mouse model, which closely recapitulates human OS. These animals, in spite of the inability to induce the autoimmune regulator, displayed a significant amelioration in thymic epithelial compartment and an important reduction of peripheral T-cell activation and tissue infiltration. Furthermore, by injecting a high number of RAG2 R229Q progenitors into RAG2 -/- animals previously conditioned with anti-CD3ε mAb, we detected autoimmune regulator expression together with the absence of peripheral immunopathology. These observations indicate that improving epithelial thymic function might ameliorate the detrimental behavior of the cell-autonomous RAG defect. Our data provide important therapeutic proof of concept for future clinical applications of anti-CD3ε mAb treatment in severe combined immunodeficiency forms characterized by poor thymus function and autoimmunity.",
author = "Veronica Marrella and Poliani, {Pietro L.} and Elena Fontana and Anna Casati and Virginia Maina and Barbara Cassani and Francesca Ficara and Manuela Cominelli and Francesca Schena and Marianna Paulis and Elisabetta Traggiai and Paolo Vezzoni and Fabio Grassi and Anna Villa",
year = "2012",
month = "8",
day = "2",
doi = "10.1182/blood-2012-01-406827",
language = "English",
volume = "120",
pages = "1005--1014",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "5",

}

TY - JOUR

T1 - Anti-CD3ε mAb improves thymic architecture and prevents autoimmune manifestations in a mouse model of Omenn syndrome

T2 - Therapeutic implications

AU - Marrella, Veronica

AU - Poliani, Pietro L.

AU - Fontana, Elena

AU - Casati, Anna

AU - Maina, Virginia

AU - Cassani, Barbara

AU - Ficara, Francesca

AU - Cominelli, Manuela

AU - Schena, Francesca

AU - Paulis, Marianna

AU - Traggiai, Elisabetta

AU - Vezzoni, Paolo

AU - Grassi, Fabio

AU - Villa, Anna

PY - 2012/8/2

Y1 - 2012/8/2

N2 - Omenn syndrome (OS) is an atypical primary immunodeficiency characterized by severe autoimmunity because of activated T cells infiltrating target organs. The impaired recombinase activity in OS severely affects expression of the pre- T-cell receptor complex in immature thymocytes, which is crucial for an efficient development of the thymic epithelial component. Anti-CD3ε monoclonal antibody (mAb) treatment in RAG2 -/- mice was previously shown to mimic pre-TCR signaling promoting thymic expansion. Here we show the effect of anti-CD3ε mAb administration in the RAG2 R229Q mouse model, which closely recapitulates human OS. These animals, in spite of the inability to induce the autoimmune regulator, displayed a significant amelioration in thymic epithelial compartment and an important reduction of peripheral T-cell activation and tissue infiltration. Furthermore, by injecting a high number of RAG2 R229Q progenitors into RAG2 -/- animals previously conditioned with anti-CD3ε mAb, we detected autoimmune regulator expression together with the absence of peripheral immunopathology. These observations indicate that improving epithelial thymic function might ameliorate the detrimental behavior of the cell-autonomous RAG defect. Our data provide important therapeutic proof of concept for future clinical applications of anti-CD3ε mAb treatment in severe combined immunodeficiency forms characterized by poor thymus function and autoimmunity.

AB - Omenn syndrome (OS) is an atypical primary immunodeficiency characterized by severe autoimmunity because of activated T cells infiltrating target organs. The impaired recombinase activity in OS severely affects expression of the pre- T-cell receptor complex in immature thymocytes, which is crucial for an efficient development of the thymic epithelial component. Anti-CD3ε monoclonal antibody (mAb) treatment in RAG2 -/- mice was previously shown to mimic pre-TCR signaling promoting thymic expansion. Here we show the effect of anti-CD3ε mAb administration in the RAG2 R229Q mouse model, which closely recapitulates human OS. These animals, in spite of the inability to induce the autoimmune regulator, displayed a significant amelioration in thymic epithelial compartment and an important reduction of peripheral T-cell activation and tissue infiltration. Furthermore, by injecting a high number of RAG2 R229Q progenitors into RAG2 -/- animals previously conditioned with anti-CD3ε mAb, we detected autoimmune regulator expression together with the absence of peripheral immunopathology. These observations indicate that improving epithelial thymic function might ameliorate the detrimental behavior of the cell-autonomous RAG defect. Our data provide important therapeutic proof of concept for future clinical applications of anti-CD3ε mAb treatment in severe combined immunodeficiency forms characterized by poor thymus function and autoimmunity.

UR - http://www.scopus.com/inward/record.url?scp=84864569919&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864569919&partnerID=8YFLogxK

U2 - 10.1182/blood-2012-01-406827

DO - 10.1182/blood-2012-01-406827

M3 - Article

C2 - 22723555

AN - SCOPUS:84864569919

VL - 120

SP - 1005

EP - 1014

JO - Blood

JF - Blood

SN - 0006-4971

IS - 5

ER -